Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
1,148,777,709
-
Total 13F shares
-
454,194,485
-
Share change
-
-1,360,163
-
Total reported value
-
$18,224,337,010
-
Put/Call ratio
-
70%
-
Price per share
-
$40.08
-
Number of holders
-
721
-
Value change
-
-$48,803,158
-
Number of buys
-
7
-
Number of sells
-
14
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q4 2013
As of 31 Dec 2013,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
721 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
454,194,485 shares.
The largest 10 holders included
Capital Research Global Investors, WELLINGTON MANAGEMENT CO LLP, FRANKLIN RESOURCES INC, Mondrian Investment Partners LTD, Allianz Asset Management AG, BARROW HANLEY MEWHINNEY & STRAUSS LLC, MACQUARIE GROUP LTD, Invesco Ltd., PointState Capital LP, and FMR LLC.
This page lists
721
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.